Rheumatoid Arthritis :: Roche’s Actemra improves rheumatoid arthritis symptoms

Results of the Option (TOcilizumab Pivotal Trial in Methotrexate Inadequate respONders) trial, the first multinational Phase III study outside of Japan, showed that patients treated with Actemra (either 4mg/kg or 8mg/kg) plus methotrexate achieved a significant and clinically important improvement in the signs and symptoms of moderate to severe rheumatoid arthritis (RA) compared to patients treated with placebo and methotrexate, a current standard of care.

Healthy :: College students less healthy than they think

Obesity, high blood pressure, high cholesterol, and inactivity: they?re not just your father?s problems any more, University of New Hampshire research finds. New data on the widely unstudied demographic of college students indicates that this group of 18 ? 24-year-olds are on the path toward chronic health diseases. Although limited, national data suggest the trend is not unique to UNH.

Infectious Disease :: Infectious diseases experts issue blueprint to avert

New vaccines are available to make significant gains against cervical cancer deaths and debilitating pain from shingles, but infectious diseases experts warn that their full potential will not be realized without changes in the way vaccines for adults and adolescents are promoted, financed and delivered in the United States.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack